MERRIMACK PHARMACEUTICALS IN - COM (MACK)

CUSIP: 590328100

Q4 2016 13F Holders as of 31 Dec 2016

Type / Class
Equity / COM
Total 13F shares
101,583,191
Share change
+5,584,091
Total reported value
$414,405,129
Put/Call ratio
224%
Price per share
$4.08
Number of holders
130
Value change
+$20,187,314
Number of buys
59
Number of sells
50

Quarterly Holders Quick Answers

What is CUSIP 590328100?
CUSIP 590328100 identifies MACK - MERRIMACK PHARMACEUTICALS IN - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of MERRIMACK PHARMACEUTICALS IN - COM (MACK) as of Q4 2016

As of 31 Dec 2016, MERRIMACK PHARMACEUTICALS IN - COM (MACK) was held by 130 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 101,583,191 shares. The largest 10 holders included FMR LLC, VANGUARD GROUP INC, WESTFIELD CAPITAL MANAGEMENT CO LP, Consonance Capital Management LP, BlackRock Fund Advisors, TIAA CREF INVESTMENT MANAGEMENT LLC, STATE STREET CORP, GREAT POINT PARTNERS LLC, FRANKLIN RESOURCES INC, and BlackRock Institutional Trust Company, N.A.. This page lists 130 institutional shareholders reporting positions in this security for the Q4 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.